<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01270412</url>
  </required_header>
  <id_info>
    <org_study_id>MMC10196-2010CTIL</org_study_id>
    <nct_id>NCT01270412</nct_id>
  </id_info>
  <brief_title>Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis</brief_title>
  <acronym>PRP</acronym>
  <official_title>Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis - A Randomized-Double-Blind Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autologous platelet-secreted growth factors (GFs) may have therapeutic effects in
      osteoarthritis (OA) capsular joints via multiple mechanisms. The aim is to examine the effect
      of a platelet-derived preparation rich in growth factors (PRGFs) in OA of the knee.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autologous platelet-secreted growth factors (GFs) may have therapeutic effects in
      osteoarthritis (OA) capsular joints via multiple mechanisms. The investigators aim is to
      examine the effect of a platelet-derived preparation rich in growth factors(PRGFs) in OA of
      the knee, using parameters of pain, function, quality of life and safety.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in pain, function, quality of life and activity level in knee osteoarthritis</measure>
    <time_frame>1 -2 years</time_frame>
    <description>Improvement in pain, function, quality of life, activity level - using scores adapted to measure these parameters in knee osteoarthritis.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Osteoarthritis of the Knee</condition>
  <arm_group>
    <arm_group_label>Platelet Rich Plasma (Preparation Rich in Growth Factors)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intra articular injection 6ml of platelet-derived preparation rich in growth factors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyaluronic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug: hyaluronic acid 20 mg / 2 ml Other Name: Arthrease</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Platelet Rich Plasma (Preparation Rich in Growth Factors)</intervention_name>
    <description>intra articular injection 6ml</description>
    <arm_group_label>Platelet Rich Plasma (Preparation Rich in Growth Factors)</arm_group_label>
    <arm_group_label>Hyaluronic acid</arm_group_label>
    <other_name>Platelet-derived preparation rich in growth factors</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyaluronic acid</intervention_name>
    <description>Intra articular injections: 20 mg / 2 ml</description>
    <arm_group_label>Hyaluronic acid</arm_group_label>
    <other_name>&quot;Arthrease&quot;</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 40-75 years old

          -  diagnosed Oa of the knee more then 1 year

          -  no knee deformation

        Exclusion Criteria:

          -  mental of physical disabilities

          -  pregnancy

          -  deformities of the knee
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lior Laver, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meir Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lior Laver, MD</last_name>
    <phone>+972-50-8464466</phone>
    <email>laver17@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar-Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Yaron Brin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guy Maoz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eyal Yaacobi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eran Dolev, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ziv Heller, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Asaf Bivas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meir Nyska, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2010</study_first_submitted>
  <study_first_submitted_qc>January 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2011</study_first_posted>
  <last_update_submitted>July 16, 2011</last_update_submitted>
  <last_update_submitted_qc>July 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 19, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Lior Laver</name_title>
    <organization>Meir Medical Center</organization>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>PRP</keyword>
  <keyword>PRGF</keyword>
  <keyword>Hyaluronic acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitogens</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

